| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $72.8M | +17.6% |
| Cost of Revenue | $68.7M | +6.8% |
| Gross Profit | $4.1M | +268.5% |
| R&D Expense | $3.1M | -54.4% |
| SG&A Expense | $15.6M | +1.9% |
| Operating Income | -$16.8M | +44.7% |
| Interest Expense | $1.9M | -18.0% |
| Income Tax | $0 | — |
| Net Income | -$18.7M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.1M | -23.9% |
| Accounts Receivable | $6.3M | +5.9% |
| Inventory | $5.8M | +42.6% |
| Current Assets | $35.3M | +0.1% |
| Total Assets | $46.6M | -4.0% |
| Current Liabilities | $17.7M | -15.6% |
| Long-term Debt | $7.6M | -42.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.4M | +48.1% |
| Investing Cash Flow | -$2.4M | -870.4% |
| Financing Cash Flow | $16.6M | +863.3% |
| +42.8% |
| EPS (Basic) | -$1.89 | -440.0% |
| EPS (Diluted) | -$1.89 | -440.0% |
| Total Liabilities |
| $32.5M |
| -29.3% |
| Stockholders' Equity | $14.1M | +456.4% |